Table 1. Clinicopathological features in stage III CRC patients with only one lymph node metastasis according the different treatment regimens.
| 5FU alone regimens (n = 230) | Oxaliplatin-based regimens (n = 76) | No Chemotherapy (n = 57) | P value | |
|---|---|---|---|---|
| Age | 64.84 ± 12.506 | 58.66 ± 12.021 | 66.77 ± 12.865 | <0.001 |
| Performance | 0.174 | |||
| 0 ~ 1 | 222 | 76 | 54 | |
| 2 | 8 | 0 | 3 | |
| Sex | 0.960 | |||
| Male | 128 | 41 | 31 | |
| Female | 102 | 35 | 26 | |
| Location | 0.254 | |||
| Right | 81 | 22 | 16 | |
| Left | 98 | 28 | 27 | |
| Sigmoid | 51 | 26 | 14 | |
| T stage | 0.069 | |||
| T1 T2 | 41 | 23 | 12 | |
| T3 T4 | 189 | 53 | 45 | |
| Differentiation | 0.599 | |||
| Well | 6 | 1 | 0 | |
| Moderate | 216 | 74 | 56 | |
| Poor | 7 | 7 | 1 | |
| CEA level | 0.272 | |||
| ≦5 | 153 | 54 | 44 | |
| >5 | 77 | 22 | 13 | |
| Invasion | 0.347 | |||
| Positive | 65 | 27 | 20 | |
| negative | 165 | 49 | 56 | |
| LN sampling | 0.128 | |||
| < 12 | 80 | 17 | 19 | |
| ≧12 | 150 | 59 | 38 |